ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,651Medicare Part D Prescriptions Filled, Including Refills

Rank: 95 out of 617

$460K Total Retail Price of All Prescriptions

Rank: 118 out of 617

551 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 551 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 551 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 8,296 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
OMEPRAZOLE 512 416 1 3
LEVOTHYROXINE SODIUM 458 361 2 1
LISINOPRIL 350 272 3 5
AMLODIPINE BESYLATE 348 324 4 6
METFORMIN HCL 323 202 5 9
FUROSEMIDE 307 253 6 4
PRAVASTATIN SODIUM 299 252 7 21
SIMVASTATIN 295 231 8 2
METOPROLOL TARTRATE 251 227 9 11
HYDROCODONE-ACETAMINOPHEN 245 121 S3 10 8
WARFARIN SODIUM 180 103 11 7
TRAMADOL HCL 176 139 12 15
HYDROCHLOROTHIAZIDE 144 143 13 13
ATENOLOL 131 124 14 17
CARVEDILOL 125 117 15 19
DIOVAN 121 121 16 41
CITALOPRAM HBR 121 109 16 18
SERTRALINE HCL 120 98 18 20
ALENDRONATE SODIUM 114 109 19 25
ALLOPURINOL 112 97 20 27
ATORVASTATIN CALCIUM 102 96 21 14
RANITIDINE HCL 96 73 22 40
ZOLPIDEM TARTRATE 96 80 22 23
FLUTICASONE PROPIONATE 95 67 24 36
JANUVIA 91 66 25 107
GABAPENTIN 90 64 26 16
MELOXICAM 87 68 27 24
POTASSIUM CHLORIDE 84 54 28 10
SPIRONOLACTONE 82 60 29 42
VERAPAMIL ER 79 79 30 90
ZETIA 77 77 31 77
NABUMETONE 74 45 32 120
CEPHALEXIN 70 58 33 68
GLIMEPIRIDE 70 68 33 33
METOPROLOL SUCCINATE 68 68 35 12
LOSARTAN POTASSIUM 68 65 35 22
ADVAIR DISKUS 66 44 37 38
CLONIDINE HCL 66 66 37 55
DONEPEZIL HCL 63 63 39 30
BENAZEPRIL-HYDROCHLOROTHIAZIDE 61 51 40 168
SYNTHROID 61 61 40 59
CRESTOR 60 60 42 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 56 42 29
AMLODIPINE BESYLATE-BENAZEPRIL 60 56 42 80
ESTRADIOL 57 43 R 45 196
ROPINIROLE HCL 57 57 45 66
LOVASTATIN 56 56 47 57
DIGOXIN 56 56 47 48
METFORMIN HCL ER 56 53 47 72
SPIRIVA 54 24 50 61
DILTIAZEM 24HR CD 54 27 50 117
PROPRANOLOL HCL 54 39 50 109
AZITHROMYCIN 51 43 53 70
TAMSULOSIN HCL 50 48 54 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 26, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.